Condition: Antiphospholipid Syndrome · Thrombosis · Anticoagulants Causing Adverse Effects in Therapeutic Use · Sponsor: Stéphane Zuily
This registry, currently being established will ensure consistency of data collection and provide safety information in non high-risk APS patients currently on DOACs.
This description comes directly from the study's public registry record.
Virginie Dufrost, MD, MSc · +33383157828 · v.dufrost@chru-nancy.Fr
Always discuss trial participation with your own doctor first.
| Stéphane Zuily | Nancy, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04262492